Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Ast5.0
Astragalus – Forschung
Begrenzte Belege
189 begutachtete Studien
Was die Evidenz sagt
Hilft vermutlich
Astragalus half in etwa der Hälfte (3/5) der Studien, die einen Effekt gemessen haben — vielversprechend, aber nicht einhellig.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 1990–2027 mit einer typischen Studiengröße von 1,222 Teilnehmenden.
Basierend auf 187 Studien · 48 Meta-Analysen · 73 RCTs · 35,739 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
3geholfen1unklar1nicht geholfen· 182 weitere ohne bewertete Effektdaten
Nach Outcome
Therapeutic & clinical
Hilft vermutlich63 Studien
Heart & blood pressure
Überwiegend Mechanismus / Beobachtung22 Studien
Immune supportVerbesserte Immunmarker in Adjuvans-Studien geringer Qualität; Datenlage zur oralen Monotherapie dünn · 4-8 weeks
Gemischte Evidenz13 Studien
Glucose & metabolic
Überwiegend Mechanismus / Beobachtung11 Studien
Energy & fatigueKeine verlässliche Evidenz beim Menschen für einen Nutzen bei Energie oder Erschöpfung · 4-8 weeks
Überwiegend Mechanismus / Beobachtung8 Studien
InflammationPolysaccharide modulieren Immunzytokine in Studien geringer Qualität · 4-8 weeks
Überwiegend Mechanismus / Beobachtung7 Studien
Longevity & agingDer Telomer-Anspruch beruht auf einer kleinen RCT sowie Tierdaten; vorläufig · Ongoing
90 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2026
199020082027
1Meta-Analysen=750 · large study2025
Einfach gesagt: Clinical application may consider older adults with immunosenescence, incorporating safety surveillance for gastrointestinal and oncological endpoints.
Su X, Wang C, Gou Z, Qu Y. · Cell biology and toxicology (2025)
Results TA-65 supplementation induced moderate telomere elongation (SMD = 0.47, 95% CI: 0.31-0.62; p < 0.00001), with amplified effects in adults > 60 years (SMD = 0.63 vs. 0.36; p = 0.03).
Industry-funded trials reported inflated efficacy (SMD = 0.63 vs. 0.40; p = 0.03).
Critically, telomere elongation did not translate to functional improvements in frailty (SMD = 0.09, p = 0.15) or inflammation (CRP/IL-6 SMD = - 0.11, p = 0.07), revealing a telomere-function disconnect.
2Fasting blood glucose levels and renal function in diabetic nephropathyMeta-Analysen=1,443 · large study2025
Einfach gesagt: Through rigorous experimental validation, our study demonstrates AS's significant clinical efficacy in managing DN.
Liang H et al. · Renal failure (2025)
Meanwhile, when the treatment duration exceeds 12 weeks, AS demonstrated a significant reduction in fasting blood glucose levels, indicating a time-dependent effect.
Through rigorous experimental validation, our study demonstrates AS's significant clinical efficacy in managing DN.
Specifically, AS has been shown to enhance renal function, ameliorate renal fibrosis, and positively influence iron metabolism.
3Diabetes management effectivenessMeta-Analysen=7,318 · very large study2025
Einfach gesagt: TCM has demonstrated considerable effectiveness in managing diabetes.
Tang S et al. · Frontiers in endocrinology (2025)
TCM has demonstrated considerable effectiveness in managing diabetes.
Through meta-analysis and network pharmacology research, this translational study establishes Level 1a evidence for TCM's antidiabetic efficacy while decoding its systems-level mechanisms.
The integrated methodology provides a paradigm for evaluating complex herbal interventions in metabolic disorders.
4CD8+ T cell count and adverse reactionsMeta-Analysen=2,648 · very large study2025
Li Q et al. · Naunyn-Schmiedeberg's archives of pharmacology (2025)
Kein klarer Effekt
← SchlechterKein EffektBesser →
Could be chance
No substantial distinctions were noted between the two groups in terms of CD8 + T cell count [MD = -1.74, 95% CI (-4.66, 1.17), P = 0.242].
Regarding adverse reactions, the incidence of symptoms such as hand-foot numbness and weakness was low, indicating a high safety profile.
Supplementation with APS can improve treatment outcomes, enhance immune function, and demonstrate a high level of safety in malignant tumor patients, making it a promising option for clinical use.
5Complete response rate, partial response rate, serum albumin, and proteinuria reductionMeta-Analysen=3,423 · very large study2023
Einfach gesagt: Adjunctive use of A membranaceus preparations combined with supportive care or immunosuppressive therapy have a promising treatment for improving complete response rate, partial response rate, serum albumin, and reducing proteinuria, serum creatinine levels compared to immunosuppressive therapy in people with MN being at moderate-high risk for disease progression.
Wang D et al. · Medicine (2023)
Given the inherent limitations of the included studies, future well-designed randomized controlled trials are required to confirm and update the findings of this analysis.
6COPD treatment effectivenessMeta-Analysen=1,070 · large study2023
Einfach gesagt: The combination of astragalus injection and ambroxol hydrochloride could be a selection of COPD patients as an adjuvant treatment.
Zhou Z et al. · Scientific reports (2023)
The combination of astragalus injection and ambroxol hydrochloride could be a selection of COPD patients as an adjuvant treatment.
However, further validation is required to evaluate the effectiveness of combining astragalus injection and ambroxol hydrochloride as an adjunctive treatment for patients with COPD.
Einfach gesagt: The combination of traditional Chinese medicine adjuvant therapy has a good curative effect on PDR patients.
Huai B et al. · Frontiers in endocrinology (2023)
The combination of traditional Chinese medicine adjuvant therapy has a good curative effect on PDR patients.
However, the relevant clinical trials are few and more high-quality clinical trials are still needed, what's more the attention should be paid to the exploration of its safety.
Einfach gesagt: The low quality of evidence suggested that adjunctive use of A. membranaceus preparations in addition to conventional therapies may be effective and tolerated for short-term reduction of albuminuria, proteinuria, and serum creatinine in DKD patients.
Zhang L et al. · Journal of ethnopharmacology (2019)
An anti-albuminuria effect was also observed in the oral A. membranaceus preparation group (four RCTs, 236 participants; SMD: 1.27 [-1.82, -0.73], I2 = 73%).
The low quality of evidence suggested that adjunctive use of A. membranaceus preparations in addition to conventional therapies may be effective and tolerated for short-term reduction of albuminuria, proteinuria, and serum creatinine in DKD patients.
The findings should be considered with caution due to the lack of high-quality RCTs and significant heterogeneity and publication bias.